生物疾病修饰性抗风湿性药物中的感染风险
Mourushi Isa1, Ma Rosario Rufina Ramos2, Shahed Kamal1
1General Medicine, Northern Health, Melbourne, AUS.
使用生物疾病修饰性抗风湿药物 (bDMARDs) 的患者可能面临感染风险增加. 本综述检查了bDMARDs的风险因素,常见感染,以及bDMARDs的风湿病患者的预防策略.
科学领域:
- 类风湿病学 类风湿病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物修饰性抗风湿药物 (bDMARDs) 对于管理炎症性风湿性疾病至关重要.
- 对于接受bDMARD治疗的患者感染风险增加存在担忧.
研究的目的:
- 审查目前关于bDMARDs的风湿病患者感染风险的证据.
- 识别易感因素,常见的传染病原体和流行感染.
- 探索bDMARD治疗的最新感染预防指南.
主要方法:
- 对研究bDMARDs和感染风险的综合文献综述.
- 分析患者数据以确定风险因素和常见病原体.
- 目前针对感染预防的临床指导方针的综合.
主要成果:
- 有证据表明,bDMARDs患者的感染易感性可能会增加.
- 特定的bDMARD药物和与患者相关的因素会影响感染风险.
- 在这个人群中确定了常见的感染和致病原体.
结论:
- 了解与bDMARDs相关的感染风险对于患者管理至关重要.
- 对于接受bDMARDs的风湿病患者来说,积极的感染预防策略至关重要.
- 更新的指导方针有助于缓解bDMARD治疗期间感染并发症.
更多相关视频
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
10:35Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
